Delisting risk
ICU · NASDAQ · Biotechnology

SeaStar Medical (ICU)

Builds extracorporeal immunomodulation cartridges for acute kidney injury care.

$2.90
At close−0.09 (−2.87%)

Something off on this page? Send us feedback.

Next report
Nov 12, 2026
in 70 days
EPS estimate
−$0.95
Revenue estimate
$500.0K
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.90−$0.44−$0.18−$1.30−$0.80−$0.90−$0.91Pending
Estimate−$0.89−$0.52−$0.43−$1.50−$0.97−$0.73−$0.97−$0.95
Surprise−1.1%+15.4%+58.1%+13.3%+17.5%−23.3%+6.2%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$67.0K$293.0K$338.0K$183.0K$420.0K$495.0K$615.0KPending
Estimate$150.0K$150.0K$245.0K$250.0K$222.5K$437.5K$486.5K$500.0K
Surprise−55.3%+95.3%+38.0%−26.8%+88.8%+13.1%+26.4%

History

DateEstimateReportedSurprise
Nov 2026−$0.95
Aug 2026−$0.97−$0.91+6.2%
May 2026−$0.73−$0.90−23.3%
Mar 2026−$0.97−$0.80+17.5%
Nov 2025−$1.50−$1.30+13.3%

The latest year is open to everyone — the 19 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Sep 2022
Aug 2022
Mar 2022
Dec 2021
Sep 2021
Jun 2021
Mar 2021
Dec 2020
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 12, 2026−$0.95$500.0K
Aug 12, 2026−$0.97−$0.91+6.2%$486.5K$615.0K+26.4%−5.7%
May 13, 2026−$0.73−$0.90−23.3%$437.5K$495.0K+13.1%−8.7%
Mar 25, 2026−$0.97−$0.80+17.5%$222.5K$420.0K+88.8%+22.4%
Nov 13, 2025−$1.50−$1.30+13.3%$250.0K$183.0K−26.8%−17.4%

The latest year is open to everyone — the 19 quarters behind it read with an account.

Sign in
Aug 13, 2025
May 14, 2025
Mar 27, 2025
Nov 13, 2024
Aug 13, 2024
May 14, 2024
Mar 13, 2024
Nov 14, 2023
Aug 14, 2023
May 15, 2023
Mar 30, 2023
Sep 30, 2022
Aug 16, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020